M1 macrophage targeting polypeptides and uses thereof
By designing and synthesizing the M1 macrophage targeting peptides M1pep1 and M1pep2, the problem of the lack of M1 macrophage targeting peptides in the existing technology was solved, and specific binding to M1 macrophages was achieved, which has good application prospects in the diagnosis and treatment of inflammatory diseases, metabolic diseases and tumors.
Patent Information
- Application Number
- CN202310464016.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-26
- Publication Date
- 2025-10-10
- Estimated Expiration
- 2043-04-26
AI Technical Summary
The existing technology lacks high-affinity and high-specificity molecular detection methods for M1 macrophages. The application of targeting peptides in M2 macrophages has been reported, but the research on M1 macrophage targeting peptides has not been reported.
Two M1 macrophage-targeting peptides, M1pep1 and M1pep2, were designed and synthesized, namely FSDDCYDCRIPR and VHAVPIRTIYYP, respectively. They were prepared by phage panning and chemical synthesis methods and used to prepare peptide-conjugated drugs and probes to achieve specific binding to M1 macrophages.
It achieves highly specific binding to M1 macrophages and has good application prospects in the diagnosis and treatment of inflammatory diseases, metabolic diseases and tumors.